Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | DNA polymerase eta | 0.0045 | 0.0543 | 0.0526 |
Echinococcus multilocularis | ewsr:fli fusion protein type | 0.001 | 0.0019 | 0.0017 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0053 | 0.0653 | 1 |
Schistosoma mansoni | ets-related | 0.0216 | 0.3094 | 0.3081 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0114 | 0.0096 |
Echinococcus granulosus | GPCR family 2 | 0.0017 | 0.0114 | 0.0113 |
Loa Loa (eye worm) | hypothetical protein | 0.0061 | 0.0774 | 0.2497 |
Echinococcus multilocularis | geminin | 0.0346 | 0.5039 | 0.5038 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0019 | 0.0055 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0024 | 0.0218 | 0.0216 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0114 | 0.0096 |
Echinococcus granulosus | ETS transcription factor Elf 2 | 0.001 | 0.0019 | 0.0017 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0053 | 0.0653 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0653 | 0.2107 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0157 | 0.1548 |
Schistosoma mansoni | hypothetical protein | 0.0346 | 0.5039 | 0.503 |
Brugia malayi | hypothetical protein | 0.0053 | 0.0653 | 0.2111 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0157 | 0.0155 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0308 | 0.029 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0679 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0543 | 0.1752 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0045 | 0.0543 | 0.8131 |
Loa Loa (eye worm) | DNA-binding protein D-ETS-3 | 0.001 | 0.0019 | 0.0055 |
Echinococcus multilocularis | protein C ets 2 | 0.001 | 0.0019 | 0.0017 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0019 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0405 | 0.1303 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.0114 | 0.037 |
Schistosoma mansoni | hypothetical protein | 0.0346 | 0.5039 | 0.503 |
Echinococcus granulosus | ETS transcription factor Elf 2 | 0.001 | 0.0019 | 0.0017 |
Schistosoma mansoni | gabp alpha | 0.0071 | 0.0928 | 0.0911 |
Echinococcus granulosus | geminin | 0.0346 | 0.5039 | 0.5038 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0157 | 0.0155 |
Echinococcus multilocularis | ETS domain containing protein Elk 1 | 0.001 | 0.0019 | 0.0017 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.0334 | 0.0316 |
Echinococcus granulosus | ETS transcription factor Elf 1 | 0.001 | 0.0019 | 0.0017 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0114 | 0.0364 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Mycobacterium ulcerans | arylamine N-acetyltransferase Nat | 0.0642 | 0.945 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0405 | 0.1308 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0053 | 0.0653 | 0.5 |
Trypanosoma brucei | unspecified product | 0.002 | 0.0157 | 0.1548 |
Echinococcus granulosus | dna polymerase kappa | 0.002 | 0.0157 | 0.0155 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.002 | 0.0157 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Loa Loa (eye worm) | ets-domain-containing protein | 0.001 | 0.0019 | 0.0055 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0024 | 0.0218 | 0.0216 |
Brugia malayi | Ets-domain containing protein | 0.0071 | 0.0928 | 0.3 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0053 | 0.0653 | 0.5 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0071 | 0.0928 | 0.2996 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0157 | 0.1548 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.0655 | 0.2116 |
Giardia lamblia | DINP protein human, muc B family | 0.002 | 0.0157 | 0.5 |
Echinococcus granulosus | protein C ets 2 | 0.001 | 0.0019 | 0.0017 |
Brugia malayi | Fli-1 protein | 0.0216 | 0.3094 | 1 |
Brugia malayi | transcription factor E74 isoform | 0.001 | 0.0019 | 0.006 |
Leishmania major | DNA polymerase eta, putative | 0.0045 | 0.0543 | 0.7789 |
Leishmania major | DNA polymerase eta, putative | 0.0032 | 0.0342 | 0.3719 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0114 | 0.0113 |
Brugia malayi | CXXC zinc finger family protein | 0.003 | 0.0308 | 0.0997 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Echinococcus multilocularis | ETS transcription factor Elf 2 | 0.001 | 0.0019 | 0.0017 |
Loa Loa (eye worm) | D-ets-2 protein | 0.001 | 0.0019 | 0.0055 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0032 | 0.0342 | 0.3719 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0423 | 0.6188 | 0.6187 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 0.0157 | 0.0502 |
Echinococcus granulosus | ETS transcription factor Elf 5 | 0.001 | 0.0019 | 0.0017 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0053 | 0.0653 | 0.5 |
Mycobacterium tuberculosis | Arylamine N-acetyltransferase Nat (arylamine acetylase) | 0.0642 | 0.945 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0114 | 0.0096 |
Echinococcus multilocularis | dna polymerase eta | 0.0045 | 0.0543 | 0.0542 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0017 | 0.0114 | 0.0364 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0114 | 0.0113 |
Brugia malayi | Ets-domain containing protein | 0.0071 | 0.0928 | 0.3 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0679 | 1 | 1 |
Onchocerca volvulus | 0.003 | 0.0308 | 0.5 | |
Echinococcus granulosus | ewsr:fli fusion protein type | 0.001 | 0.0019 | 0.0017 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0056 | 0.0706 | 1 |
Echinococcus granulosus | dnaJ subfamily B | 0.0423 | 0.6188 | 0.6187 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.0334 | 0.0316 |
Leishmania major | hypothetical protein, conserved | 0.0053 | 0.0653 | 1 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.002 | 0.0157 | 0.5 |
Echinococcus multilocularis | ETS transcription factor Elf 2 | 0.001 | 0.0019 | 0.0017 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.002 | 0.0157 | 0.0139 |
Echinococcus multilocularis | GPCR, family 2 | 0.0017 | 0.0114 | 0.0113 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0157 | 0.0508 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.001 | 0.0019 | 0.0055 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0405 | 0.0387 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0071 | 0.0928 | 0.0926 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.002 | 0.0157 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0423 | 0.6188 | 0.6181 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0157 | 0.1548 |
Echinococcus granulosus | ETS domain containing protein Elk 1 | 0.001 | 0.0019 | 0.0017 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0045 | 0.0543 | 0.1757 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.0655 | 0.2116 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0053 | 0.0653 | 0.856 |
Echinococcus multilocularis | ETS transcription factor Elf 5 | 0.001 | 0.0019 | 0.0017 |
Echinococcus granulosus | dna polymerase eta | 0.0045 | 0.0543 | 0.0542 |
Echinococcus multilocularis | cpg binding protein | 0.0031 | 0.0334 | 0.0332 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.0114 | 0.037 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0045 | 0.0543 | 0.7789 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0063 | 0.0806 | 0.0789 |
Loa Loa (eye worm) | fli-1 protein | 0.0216 | 0.3094 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Brugia malayi | hypothetical protein | 0.0034 | 0.0374 | 0.1208 |
Echinococcus multilocularis | ETS transcription factor Elf 1 | 0.001 | 0.0019 | 0.0017 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0114 | 0.0113 |
Brugia malayi | Ets-domain containing protein | 0.001 | 0.0019 | 0.006 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0655 | 0.2111 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0114 | 0.0096 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.0655 | 0.2111 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0053 | 0.0653 | 1 |
Echinococcus multilocularis | ets variant gene 4 | 0.001 | 0.0019 | 0.0017 |
Echinococcus granulosus | cpg binding protein | 0.0031 | 0.0334 | 0.0332 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0218 | 0.02 |
Brugia malayi | DNA-binding protein D-ETS-3 | 0.001 | 0.0019 | 0.006 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0157 | 0.1548 |
Echinococcus multilocularis | dna polymerase kappa | 0.002 | 0.0157 | 0.0155 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0071 | 0.0928 | 0.0926 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.002 | 0.0157 | 0.0139 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0114 | 0.0113 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.003 | 0.0308 | 0.0992 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.